Dr. Amy Law is a recognized medical oncologist in Rancho Mirage, California. She received her medical diploma from Tufts University School of Medicine in 1992. Dr. Law completed her medical education with a residency in internal medicine and a fellowship in hematology/ oncology, both at Tufts Medical Center. Her subspecialties are general oncology and hematologic oncology. She is certified by the American Board in medical oncology and internal medicine and currently works at Eisenhower Medical Center. In 2007 she published the article “Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma...” in collaboration with other doctors. She is a member of the American Society of Clinical Oncology. Besides English, she can speak German and Spanish.
Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma...
Dr. Amy Law is a recognized medical oncologist in Rancho Mirage, California. She received her medical diploma from Tufts University School of Medicine in 1992. Dr. Law completed her medical education with a residency in internal medicine and a fellowship in hematology/ oncology, both at Tufts Medical Center. Her subspecialties are general oncology and hematologic oncology. She is certified by the American Board in medical oncology and internal medicine and currently works at Eisenhower Medical Center. In 2007 she published the article “Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma...” in collaboration with other doctors. She is a member of the American Society of Clinical Oncology. Besides English, she can speak German and Spanish.
Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma...